Research demonstrates that the aberrant expression of PD-1 and other immune checkpoints, including TIM-3 and LAG-3, is prevalent within the microenvironment of DLBCL, particularly associated with aggressive disease behavior [18]. The gene discussed is HAVCR2; the disease is diffuse large B-cell lymphoma.